How should I evaluate and manage a patient with new pressure-like jaw pain that may indicate an acute coronary syndrome?

Evaluation and Management of Heart-Related Jaw Pain

Immediately obtain a 12-lead ECG and initiate aspirin 162-325 mg orally while simultaneously assessing for STEMI, as jaw pain is an anginal equivalent that requires urgent ACS evaluation. 1

Initial Assessment and Risk Stratification

When a patient presents with new pressure-like jaw pain concerning for ACS, your evaluation must proceed rapidly and systematically:

Immediate Actions (Within 10 Minutes)

• Obtain 12-lead ECG - Look specifically for ST-segment elevation, ST-segment depression, or any evidence of ischemia 2
• Administer aspirin 162-325 mg loading dose immediately unless absolute contraindication exists 1
• Draw high-sensitivity cardiac troponin (hs-cTn) at presentation 2
• Assess hemodynamic stability - blood pressure, heart rate, oxygen saturation

Key Clinical Features to Identify

The most diagnostically useful findings include 3:

• Radiation to both arms (specificity 96%, LR 2.6) - though jaw radiation alone is significant
• Prior abnormal stress test (specificity 96%, LR 3.1)
• Peripheral arterial disease (specificity 97%, LR 2.7)
• ST-segment depression on ECG (specificity 95%, LR 5.3)
• Any ECG evidence of ischemia (specificity 91%, LR 3.6)

Diagnostic Pathway Based on Initial Troponin

If hs-cTnI <5 ng/L or hs-cTnT <6 ng/L at ≥3 hours from symptom onset:

You can safely rule out MI and discharge with outpatient follow-up if the patient also has:

• Non-ischemic ECG
• Low HEART score (≤3) or TIMI score (0-1) 2, 3

The low-risk HEART score has an LR of 0.20 for ACS, making it highly effective for exclusion 3.

If hs-cTn is between 5 ng/L and 99th percentile (intermediate risk):

Repeat hs-cTn at 3 hours and perform risk stratification 2:

• If no significant increase AND low modified HEART score (≤3) or recent normal testing: consider discharge with outpatient stress testing
• If rising troponin or higher risk score: proceed to admission and further evaluation

If hs-cTn >99th percentile or rising significantly:

This indicates myocardial injury requiring admission and likely invasive evaluation 2. Classify as type 1 MI, type 2 MI, acute myocardial injury, or chronic myocardial injury based on clinical context.

Acute Symptom Management

For Ongoing Jaw/Chest Pain:

Administer sublingual nitroglycerin 0.3-0.4 mg every 5 minutes up to 3 doses if 1:

• Systolic BP ≥90 mmHg
• No recent PDE5 inhibitor use (12h for avanafil, 24h for sildenafil/vardenafil, 48h for tadalafil)
• No suspected right ventricular infarction

If pain persists despite nitroglycerin, use IV morphine 2-4 mg or fentanyl 25-50 μg, though be aware this may delay oral P2Y12 inhibitor absorption 1. The goal is pain relief to prevent sympathetic activation, but analgesics don't improve clinical outcomes—they're for symptom management only.

Critical Pitfalls to Avoid:

• Never use NSAIDs for ischemic pain - they increase MACE risk without benefit 1
• Don't give nitrates if BP <90 mmHg or recent PDE5 inhibitor use
• Don't rely on clinical judgment alone - history and physical examination cannot reliably exclude ACS 3
• Don't discharge based on single troponin if drawn <3 hours from symptom onset 2

Ongoing Management

After initial aspirin loading dose, continue low-dose aspirin 75-100 mg daily - this is superior to continuing full-dose aspirin and reduces bleeding risk 1. The evidence shows that 300-325 mg daily for 30 days was not superior to 75-100 mg for MACE reduction but increased bleeding.

Supplemental oxygen is only indicated if SpO2 <90% - routine oxygen doesn't improve outcomes 1.

The strength of this approach is based on the 2025 ACC/AHA/ACEP guidelines 1 combined with the 2022 ACC chest pain evaluation pathway 2, which provide the most current evidence-based framework. The HEART and TIMI scores have robust validation for risk stratification 3, making them essential tools when troponin results place patients in the intermediate zone.